🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Ragweed is the primary cause of autumn allergies. The ragweed season begins...
Status
Completed
Location
Cetero Research
Start Date
2011-10
Trial ID
NCT01448603
Treatments Being Tested
The ragweed Ambrosia artemisiifolia is spreading in northern Europe due to ...
Status
Completed
Location
Fraunhofer Institute for Toxicology and Experimental Medicine
Start Date
2022-09-01
Trial ID
NCT05346718
Treatments Being Tested
The present study investigates the reaction of the skin upon exposure to ho...
Status
Completed
Location
Fraunhofer Institute for Toxicology and Experimental Medicine
Start Date
2021-09-10
Trial ID
NCT05019209
Treatments Being Tested
The objective of this study is to assess the effect of 'Eucerin AtopiContro...
Status
Completed
Location
Fraunhofer ITEM
Start Date
2017-10-02
Trial ID
NCT03315611
Treatments Being Tested
Intranasal corticosteroids are accepted as safe and effective first-line th...
Status
Completed
Location
Vienna Challenge Chamber
Start Date
2018-11-19
Trial ID
NCT03755557
The purpose of this study is to determine the safety and effect of CAL-263 ...
Status
Completed
Location
Vienna Challenge Chamber
Start Date
2010-01
Trial ID
NCT01066611
This study aims to evaluate the effectiveness and safety of ALDP001 Nasal S...
Status
Recruiting
Location
Cliantha Research
Start Date
2025-10-17
Trial ID
NCT07219849
Treatments Being Tested
House Dust Mites (HDM) are arachnids that infest bedding, carpet, upholster...
Status
Completed
Location
Multiple Locations
Start Date
2013-09
Trial ID
NCT01923792
Allergic rhinitis is an inflammatory disorder of the upper airway that occu...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-04
Trial ID
NCT00118729
Treatments Being Tested
This is a Phase 2a study to evaluate the efficacy and safety of Norketotife...
Status
Completed
Location
Biogenics Research Chamber
Start Date
2019-04-01
Trial ID
NCT03887026
Treatments Being Tested